|
General Information
|
|
|
Product
|
Cyclin D1 Peptide
|
|
Description
|
Antigenic Blocking Peptide G1/S-specific cyclin-D1 Antibody N-epitope
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Peptide Description
|
Synthetic Peptide
|
|
Accession #
|
GenBank: AAH23620.1
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Determinant
|
N-epitope
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
P24385
|
|
Overview
|
Regulatory component of the cyclin D1-CDK4 complex that phosphorylates and inhibits members of retinoblastoma protein family including RB1 and regulates the cell-cycle during G1/S transition.
|
|
Molecular Function
|
Cell cycle; Cell division; DNA damage; Transcription regulation
|
|
Subcellular Location
|
Cytoplasm; Membrane; Nucleus
|
|
Structure
|
Belongs to the Cyclin D subfamily. Contains 1 cyclin N-terminal domain
|
|
Alternative Nomenclature
|
B cell CLL/lymphoma 1 antibody
CCND 1 antibody
Cyl 1 antibody
G1/S specific cyclin D1 antibody
Parathyroid adenomatosis 1 antibody
PRAD1 antibody
U21B31 antibody
|
| |
|
Cyclin D1 Antibody
Cyclin D1 Antibody FITC
Cyclin D1 Antibody BIOTIN
Cyclin D1 Positive Control
